Article info
PDFIschemic stroke
Original research
Frontline ADAPT therapy to treat patients with symptomatic M2 and M3 occlusions in acute ischemic stroke: initial experience with the Penumbra ACE and 3MAX reperfusion system
- Correspondence to Dr Jens Altenbernd, Department of Radiology, Neuroradiology and Nuclear Medicine, Knappschaftskrankenhaus Recklinghausen – Klinikum Vest, Dorstener Straße 151, Recklinghausen 45657, Germany; jens.altenbernd{at}gmail.com
Citation
Frontline ADAPT therapy to treat patients with symptomatic M2 and M3 occlusions in acute ischemic stroke: initial experience with the Penumbra ACE and 3MAX reperfusion system
Publication history
- Received June 1, 2017
- Revised July 20, 2017
- Accepted July 25, 2017
- First published August 18, 2017.
Online issue publication
April 13, 2018
Article Versions
- Previous version (18 August 2017).
- Previous version (30 September 2017).
- Previous version (12 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/